Early cardiovascular damage may begin much sooner than previously recognized, with new evidence suggesting that fatty liver disease creates measurable arterial changes in children as young as five years old. This connection between liver health and heart disease risk represents a critical shift in understanding pediatric metabolic health trajectories.
Mexican researchers examined 200 children with varying degrees of metabolic dysfunction, finding that those diagnosed with metabolic-associated steatotic liver disease (MASLD) showed significantly thicker carotid artery walls—a key marker of cardiovascular aging. The affected children demonstrated carotid intima-media thickness of 0.738mm compared to 0.56mm in controls, alongside dramatically elevated insulin resistance scores (7.55 versus 3.62) and higher systolic blood pressure readings. Most concerning, these children maintained BMI percentiles near the 98th percentile, indicating severe obesity patterns.
This pediatric evidence strengthens the emerging understanding that liver metabolism and cardiovascular health operate as interconnected systems rather than separate disease pathways. The study's predictive model, incorporating arterial thickness measurements with liver enzymes and metabolic markers, achieved 93.5% accuracy in identifying cardiovascular risk—suggesting these combined assessments could revolutionize pediatric health screening protocols.
The findings carry particular weight given the rising prevalence of childhood obesity across Latin American populations. While previous research established adult connections between fatty liver and heart disease, demonstrating measurable arterial changes in children suggests the cardiovascular consequences of metabolic dysfunction manifest within years rather than decades. However, the cross-sectional design limits conclusions about disease progression, and the single-center Mexican cohort may not reflect broader pediatric populations.